Technical and economic feasibility of gradual concentric chambers reactor for sewage treatment in developing countries
Full Text
Reprint PDF

Keywords

developing countries
mesophilic
nutrients removal
reactor design
sewage

How to Cite

1.
Mendoza L, Carballa M, Sitorus B, Pieters J, Verstraete W. Technical and economic feasibility of gradual concentric chambers reactor for sewage treatment in developing countries. Electron. J. Biotechnol. [Internet]. 2009 Apr. 15 [cited 2024 Dec. 22];12(2):0-. Available from: https://www.ejbiotechnology.info/index.php/ejbiotechnology/article/view/v12n2-8

Abstract

A major challenge in developing countries concerning domestic wastewaters is to decrease their treatment costs. In the present study, a new cost-effective reactor called gradual concentric chambers (GCC) was designed and evaluated at lab-scale. The effluent quality of the GCC reactor was compared with that of an upflow anaerobic sludge bed (UASB) reactor. Both reactors showed organic matter removal efficiencies of 90%; however, the elimination of nitrogen was higher in the GCC reactor. The amount of biogas recovered in the GCC and the UASB systems was 50% and 75% of the theoretical amount expected, respectively, and both reactors showed a slightly higher methane production when the feed was supplemented with an additive based on vitamins and minerals. Overall, the economical analysis, the simplicity of design and the performance results revealed that the GCC technology can be of particular interest for sewage treatment in developing countries.

Full Text
Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.